Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josepa Mauri

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Open Heart|April 17, 2026
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in CataloniaBenjamin Casteigt, Emili Vela, Ermengol Valles, et al.
European Journal of Preventive Cardiology|May 10, 2021
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrantsPriyanka Satish, Emili Vela, Usama Bilal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2019
Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018Emanuele Barbato, Josepa Mauri, Robert A Byrne, et al.
Journal of the American College of Cardiology|September 20, 2014
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trialAntonio Colombo, Alaide Chieffo, Arian Frasheri, et al.
The American Journal of Cardiology|July 2, 2018
Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry)Cosme García-García, Teresa Oliveras, Ferran Rueda, et al.
European Heart Journal|August 22, 2023
Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and managementPhilip Moons, Tone M Norekvål, Elena Arbelo, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Socioeconomic Status and Prognosis of Patients With ST-Elevation Myocardial Infarction Managed by the Emergency-Intervention "Codi IAM" NetworkHelena Tizón-Marcos, Beatriz Vaquerizo, Josepa Mauri Ferré, et al.
Journal of the American Heart Association|October 15, 2020
Trends in Short- and Long-Term ST-Segment-Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population-Based ST-Segment-Elevation Myocardial Infarction RegistryCosme García-García, Teresa Oliveras, Jordi Serra, et al.
Revista Espanola De Cardiologia (English Ed.)|December 10, 2021
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomesAida Ribera, Josep R Marsal, María T Faixedas, et al.
International Journal of Cardiology|January 25, 2016
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudyGiuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Open Heart|April 17, 2026
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in CataloniaBenjamin Casteigt, Emili Vela, Ermengol Valles, et al.
European Journal of Preventive Cardiology|May 10, 2021
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrantsPriyanka Satish, Emili Vela, Usama Bilal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2019
Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018Emanuele Barbato, Josepa Mauri, Robert A Byrne, et al.
Journal of the American College of Cardiology|September 20, 2014
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trialAntonio Colombo, Alaide Chieffo, Arian Frasheri, et al.
The American Journal of Cardiology|July 2, 2018
Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry)Cosme García-García, Teresa Oliveras, Ferran Rueda, et al.
European Heart Journal|August 22, 2023
Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and managementPhilip Moons, Tone M Norekvål, Elena Arbelo, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Socioeconomic Status and Prognosis of Patients With ST-Elevation Myocardial Infarction Managed by the Emergency-Intervention "Codi IAM" NetworkHelena Tizón-Marcos, Beatriz Vaquerizo, Josepa Mauri Ferré, et al.
Journal of the American Heart Association|October 15, 2020
Trends in Short- and Long-Term ST-Segment-Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population-Based ST-Segment-Elevation Myocardial Infarction RegistryCosme García-García, Teresa Oliveras, Jordi Serra, et al.
Revista Espanola De Cardiologia (English Ed.)|December 10, 2021
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomesAida Ribera, Josep R Marsal, María T Faixedas, et al.
International Journal of Cardiology|January 25, 2016
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudyGiuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, et al.
Pageof 10